Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment

Almojtaba AbdAlkhalig Ahmed Bakheet

doi:doi:10.11648/j.sr.20180601.14

| Peer-Reviewed

Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment

Almojtaba AbdAlkhalig Ahmed Bakheet

Published in Science Research (Volume 6, Issue 1)

Received: 11 December 2017 Accepted: 30 January 2018 Published: 27 February 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

This review gives a survey on the representative role concerning the nutritional care of valve heart disease patients under warfarin drug treatment, the objectives of this work is to give a nutritional views to the valve heart disease from the disease definition, determining Risks, Complications, surgical outcome and risk of procedure, It also highlights the blood coagulation, warfarin drug and its effects and the role of nutritional support in the treatment of valve heart disease patients.

Published in	Science Research (Volume 6, Issue 1)
DOI	10.11648/j.sr.20180601.14
Page(s)	24-28
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

Valve Heart Disease, Warfarin Drug and Its Effects, Nutritional Support

References

[1]	American Heart Association, Inc -- 10000056 Heart and Stroke Encyclopedia. American Heart Association, Inc. Retrieved 2010-08-05.
[2]	Jr S S, Allen J, Blair S N, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.[J]. Journal of the American College of Cardiology, 2006, 47(10): 2130-9.
[3]	Vukasinović M, Djukić V, Stanković P, et al. International Statistical Classification of Diseases and Related Health Problems [J]. Acta Chirurgica Iugoslavica, 2009, 56 (3): 65-9.
[4]	Andersohn F, Suissa S, Garbe E. Cyclooxygenase inhibitors and cardiovascular risk [J]. Jama the Journal of the American Medical Association, 2007, 297 (6): 587-8.
[5]	Torracca L, Schreuder J J, Quarti A, et al. Acute effects of beating heart coronary surgery on left ventricular performance. [J]. Annals of Thoracic Surgery, 2002, 74(4): 1348-1352.
[6]	Wajima T, Isbister G K, Duffull S B. A comprehensive model for the humoral coagulation network in humans. [J]. Clinical Pharmacology & Therapeutics, 2009, 86 (3): 290–298.
[7]	Guyton, Arthur C. Guyton and Hall textbook of medical physiology/[M]. Saunders/Elsevier, 2011.
[8]	Harris J. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc. 1995; 95: 580-584.
[9]	Calonge N, Petitti D B, Dewitt T G, et al. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.[J]. Annals of Internal Medicine, 2009, 150 (6): 396.
[10]	Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. [J]. Journal of the American College of Cardiology, 2003, 107(12): 1692.
[11]	Goldhaber S Z. Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized? [J]. Annals of Internal Medicine, 2009, 150(9): 644-646.
[12]	Yamreudeewong W, Henann N, Fazio A, Lower D, Cassidy T. Drug-food interactions in clinical practice. J Fam Pract. 1995; 40(4): 376-384.
[13]	Brigden M. Oral anticoagulant therapy. Postgrad Med 1996; 99(6): 81-100.
[14]	Girolami A, Scandellari R, Zanon E, et al. Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. [J]. Journal of Thrombosis & Thrombolysis, 2006, 21(3): 279-84.
[15]	Couris R, Tataronis G, Mccloskey W, et al. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices[J]. International journal for vitamin and nutrition research. Internationale Zeitschriftfür Vitamin- und Ernährungsforschung. Journal international de vitaminologieet de nutrition, 2006, 76(2): 65.
[16]	Izzo A A, Carlo G D, Borrelli F, et al. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction[J]. International Journal of Cardiology, 2005, 98(1): 1.

Cite This Article

Plain Text BibTeX RIS

APA Style

Almojtaba AbdAlkhalig Ahmed Bakheet. (2018). Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment. Science Research, 6(1), 24-28. https://doi.org/10.11648/j.sr.20180601.14

Copy | Download

ACS Style

Almojtaba AbdAlkhalig Ahmed Bakheet. Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment. Sci. Res. 2018, 6(1), 24-28. doi: 10.11648/j.sr.20180601.14

Copy | Download

AMA Style

Almojtaba AbdAlkhalig Ahmed Bakheet. Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment. Sci Res. 2018;6(1):24-28. doi: 10.11648/j.sr.20180601.14

Copy | Download

@article{10.11648/j.sr.20180601.14,
  author = {Almojtaba AbdAlkhalig Ahmed Bakheet},
  title = {Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment},
  journal = {Science Research},
  volume = {6},
  number = {1},
  pages = {24-28},
  doi = {10.11648/j.sr.20180601.14},
  url = {https://doi.org/10.11648/j.sr.20180601.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sr.20180601.14},
  abstract = {This review gives a survey on the representative role concerning the nutritional care of valve heart disease patients under warfarin drug treatment, the objectives of this work is to give a nutritional views to the valve heart disease from the disease definition, determining Risks, Complications, surgical outcome and risk of procedure, It also highlights the blood coagulation, warfarin drug and its effects and the role of nutritional support in the treatment of valve heart disease patients.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment
AU  - Almojtaba AbdAlkhalig Ahmed Bakheet
Y1  - 2018/02/27
PY  - 2018
N1  - https://doi.org/10.11648/j.sr.20180601.14
DO  - 10.11648/j.sr.20180601.14
T2  - Science Research
JF  - Science Research
JO  - Science Research
SP  - 24
EP  - 28
PB  - Science Publishing Group
SN  - 2329-0927
UR  - https://doi.org/10.11648/j.sr.20180601.14
AB  - This review gives a survey on the representative role concerning the nutritional care of valve heart disease patients under warfarin drug treatment, the objectives of this work is to give a nutritional views to the valve heart disease from the disease definition, determining Risks, Complications, surgical outcome and risk of procedure, It also highlights the blood coagulation, warfarin drug and its effects and the role of nutritional support in the treatment of valve heart disease patients.
VL  - 6
IS  - 1
ER  -

Copy | Download

Author Information

Almojtaba AbdAlkhalig Ahmed Bakheet

Department of Family Sciences (Nutrition and Dietetics), Faculty of Education, University of Khartoum, Khartoum, Sudan

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Almojtaba AbdAlkhalig Ahmed Bakheet. (2018). Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment. Science Research, 6(1), 24-28. https://doi.org/10.11648/j.sr.20180601.14

Copy | Download

ACS Style

Almojtaba AbdAlkhalig Ahmed Bakheet. Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment. Sci. Res. 2018, 6(1), 24-28. doi: 10.11648/j.sr.20180601.14

Copy | Download

AMA Style

Almojtaba AbdAlkhalig Ahmed Bakheet. Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment. Sci Res. 2018;6(1):24-28. doi: 10.11648/j.sr.20180601.14

Copy | Download

@article{10.11648/j.sr.20180601.14,
  author = {Almojtaba AbdAlkhalig Ahmed Bakheet},
  title = {Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment},
  journal = {Science Research},
  volume = {6},
  number = {1},
  pages = {24-28},
  doi = {10.11648/j.sr.20180601.14},
  url = {https://doi.org/10.11648/j.sr.20180601.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sr.20180601.14},
  abstract = {This review gives a survey on the representative role concerning the nutritional care of valve heart disease patients under warfarin drug treatment, the objectives of this work is to give a nutritional views to the valve heart disease from the disease definition, determining Risks, Complications, surgical outcome and risk of procedure, It also highlights the blood coagulation, warfarin drug and its effects and the role of nutritional support in the treatment of valve heart disease patients.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment
AU  - Almojtaba AbdAlkhalig Ahmed Bakheet
Y1  - 2018/02/27
PY  - 2018
N1  - https://doi.org/10.11648/j.sr.20180601.14
DO  - 10.11648/j.sr.20180601.14
T2  - Science Research
JF  - Science Research
JO  - Science Research
SP  - 24
EP  - 28
PB  - Science Publishing Group
SN  - 2329-0927
UR  - https://doi.org/10.11648/j.sr.20180601.14
AB  - This review gives a survey on the representative role concerning the nutritional care of valve heart disease patients under warfarin drug treatment, the objectives of this work is to give a nutritional views to the valve heart disease from the disease definition, determining Risks, Complications, surgical outcome and risk of procedure, It also highlights the blood coagulation, warfarin drug and its effects and the role of nutritional support in the treatment of valve heart disease patients.
VL  - 6
IS  - 1
ER  -

Copy | Download